examples | R Documentation |
A list of 6 qmd_info
examples on the pharmacokinetic
models for nevirapine (onecomp
), miltefosine (twocomp
),
ciclosporin (threecomp
), felodipine (gitt
), bedaquiline (metabolite
) and
theophylline (pbpk
).
A list of 6 levels: onecomp
, twocomp
, threecomp
,
gitt
metabolite
and pbpk
.
The examples
file contains the following:
examples$onecomp
nevirapine PK model qmd_info
examples$twocomp
miltefosine PK model qmd_info
examples$threecomp
ciclosporin PK model qmd_info
examples$gitt
felodipine PK model qmd_info
examples$metabolite
bedaquiline PK model qmd_info
examples$pbpk
theophylline PBPK model qmd_info
Each of these examples contain the following:
descr model description
theta theta typical values and RSE (%) for fixed effects
omega omega typical values (%) and RSE (%) for inter subject variability
data individual model parameter read from a patab file
advan nonmem ADVAN subroutine
parsed_comp the parsed compartment information
parsed_arrow the parsed arrow information
onecomp: D. Elsherbiny et al. Population pharmacokinetics of nevirapine in combination with rifampicin-based short course chemotherapy in HIV- and tuberculosis-infected South African patients. Eur J Clin Pharmacol. 65:71–80. (2009)
twocomp: T. Dorlo et al. Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients. Antimicrob. Agents Chemother. 52:8, 2855–2860. (2008)
threecomp: S. Fanta et al. Developmental pharmacokinetics of ciclosporin – a population pharmacokinetic study in paediatric renal transplant candidates. British Journal of Clinical Pharmacology. 64:6, 772–784. (2007)
gitt: E. Hénin et al. A mechanism-Based Approach for Absorption Modeling: The Gastro-Intestinal Transit Time (GITT) Model. The AAPS Journal, 14:2, 155-163. (2012)
metabolite: E. Svensson et al. Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis. Antimicrobial Agents and Chemotherapy, 57:6, 2780-2787. (2013)
pbpk: S. Björkman. Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs. British Journal of Clinical Pharmacology. 59:6, 691–704. (2004)
## Not run:
# One-compartment model
qmd(examples$onecomp)
# Two-compartment model
qmd(examples$twocomp)
# Three-compartment model
qmd(examples$threecomp)
# GITT model
qmd(examples$gitt, rank = c(1,2,2,2,2,2,3,4,5,5))
# Metabolite
qmd(examples$metabolite, rank = c(1,2,3,4,5,6,7,7,6,7,6,7))
# PBPK model
qmd(examples$pbpk, pbpk_layout = TRUE)
## End(Not run)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.